v3.24.1.u1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues:    
Total revenue $ 8,189 $ 5,609
Operating expenses:    
Cost of sales 627 554
Research and development 68,620 67,301
Selling, general and administrative 31,014 28,367
Total operating expenses 100,261 96,222
Loss from operations (92,072) (90,613)
Interest income, net 8,889 8,091
Other income, net 1,634 1,504
Net loss $ (81,549) $ (81,018)
Net loss per share - basic (in usd per share) $ (1.45) $ (1.47)
Net loss per share - diluted (in usd per share) $ (1.45) $ (1.47)
Weighted-average number of common shares used in computing net loss per share - basic (in shares) 56,383,475 55,265,390
Weighted-average number of common shares used in computing net loss per share – diluted (in shares) 56,383,475 55,265,390
Product revenue, net    
Revenues:    
Total revenue $ 8,189 $ 5,609